$8.050
-0.336 (-4.17%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
IBRX Prediction & Forecast by Similar Chart Analysis
Alphio's IBRX stock price prediction model matches the current Immunitybio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.00 (-0.68%). The 1-week path is $8.41 (+4.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Immunitybio Inc Stock?
ImmunityBio Inc (IBRX) is a good buy right now due to its current price of $8.05, which is significantly lower than the analyst price target of $12, indicating a potential upside of 49%. Additionally, the stock has shown a remarkable year-to-date change of +298.51%, reflecting strong investor interest and momentum. The main risk is the negative net income, which reached -632,782,000 USD in Q1 2026, highlighting ongoing financial challenges that investors should monitor closely.
IBRX stock price ended at $8.05 on Friday, after losing -4.17%
Immunitybio Inc (IBRX) last closed at $8.05, losing -4.17%. These facts feed the 1-day and 1-week IBRX price prediction above.
Forecast Drivers
Immunitybio Inc (IBRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches IBRX, ranked by similarity.
Seasonality analysis for IBRX
Historically the probability of a positive August return for IBRX is 34.92%. June offers the highest probability of a positive month at 100.00%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for IBRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $4.27 | $6.06 | $8.95 | -24.74% |
| Sep 2026 | $2.84 | $5.47 | $6.36 | -32.09% |
| Oct 2026 | $7.28 | $8.00 | $10.86 | -0.67% |
| Nov 2026 | $5.69 | $6.03 | $7.67 | -25.08% |
| Dec 2026 | $4.16 | $6.10 | $7.21 | -24.23% |
In 2026, Immunitybio Inc (IBRX) is projected to range from $2.84 to $10.86.
Immunitybio Inc 2026 monthly forecast
In Aug 2026, Immunitybio Inc is projected to average $6.06, with a low of $4.27 and high of $8.95.
In Sep 2026, Immunitybio Inc is projected to average $5.47, with a low of $2.84 and high of $6.36.
In Oct 2026, Immunitybio Inc is projected to average $8.00, with a low of $7.28 and high of $10.86.
In Nov 2026, Immunitybio Inc is projected to average $6.03, with a low of $5.69 and high of $7.67.
In Dec 2026, Immunitybio Inc is projected to average $6.10, with a low of $4.16 and high of $7.21.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.